Debiopharm (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Debiopharm" in English language version.

refsWebsite

Global rank English rank

7manufacturingchemist.com

low place

6nih.gov

4^th place

4doi.org

2^nd place

3handle.net

102^nd place

76^th place

2bloomberg.com

99^th place

77^th place

2letemps.ch

1,980^th place

6,626^th place

2reuters.com

49^th place

47^th place

1bioalps.org

low place

1ggba.swiss

low place

1canal9.ch

low place

1theark.ch

low place

1fuw.ch

low place

1arznei-news.de

low place

1cancer.gov

1,684^th place

1,350^th place

1invivomagazine.com

low place

1pme.ch

low place

1endpts.com

low place

1business-monitor.ch

low place

1lenouvelliste.ch

low place

1pharmaphorum.com

low place

1finsmes.com

low place

1mddionline.com

low place

1yahoo.com

38^th place

40^th place

1mobihealthnews.com

low place

1moneyhouse.ch

low place

124heures.ch

5,984^th place

low place

1informa.com

low place

1pharmabiz.com

low place

1thepharmaletter.com

low place

1fiercebiotech.com

low place

8,828^th place

1oncozine.com

low place

1bioprocessonline.com

low place

1clinicaltrials.gov

5,225^th place

4,062^nd place

1pharmaceutical-technology.com

low place

24heures.ch (Global: 5,984^th place; English: low place)

"Biotechnologies et finances: Quand le «capital management» soutient le développement de médicaments". 24 heures (in French). 2024-09-23. Retrieved 2025-02-20.

arznei-news.de (Global: low place; English: low place)

Christian Hilscher (2017-03-23). "Triptorelin". ArzneiNews (in German).

bioalps.org (Global: low place; English: low place)

"Debiopharm lays the foundation stone for its new building". BioAlps. 2024-09-12. Retrieved 2025-02-20.

bioprocessonline.com (Global: low place; English: low place)

"ADCs: Leading With The Linker". www.bioprocessonline.com. Retrieved 2025-02-20.

bloomberg.com (Global: 99^th place; English: 77^th place)

"Debiopharm Group". Bloomberg. Retrieved 2016-05-12.
"Debiopharm International". Bloomberg. Retrieved May 12, 2016.

business-monitor.ch (Global: low place; English: low place)

"Après-demain SA". Business Monitor.

canal9.ch (Global: low place; English: low place)

"Debiopharm investit. "J'ai fondé cette entreprise à Martigny", se souvient Rolland-Yves Mauvernay". Canal9 (in French). 2015-09-17.

cancer.gov (Global: 1,684^th place; English: 1,350^th place)

"Oxaliplatin - NCI". www.cancer.gov. 2006-10-05. Retrieved 2023-02-13.

clinicaltrials.gov (Global: 5,225^th place; English: 4,062^nd place)

A Phase 1b Study in Patients With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) to Characterize the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Debio 4126, a 12-week Prolonged-release Octreotide Formulation (Report). clinicaltrials.gov. 2025-02-10.

doi.org (Global: 2^nd place; English: 2^nd place)

Guillaume Ploussard; Pierre Mongiat-Artus (2013). "Triptorelin in the management of prostate cancer". Future Oncology (London, England). 9 (1): 93–102. doi:10.2217/fon.12.158. PMID 23252566.
Zhu, L.; Guan, Z.; Huang, Y.; Hua, K.; Ma, L.; Zhang, J.; Yang, D.; Perrot, V.; Li, H.; Zhang, X. (2022-02-04). "The efficacy and safety of triptorelin-therapy following conservative surgery for deep infiltrating endometriosis". Medicine. 101 (5) e28766. doi:10.1097/MD.0000000000028766. PMC 8812645. PMID 35119037.
"Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck". 2022-02-17. doi:10.2217/fon-2021-1634. hdl:2434/1198462. PMID 35172587. {{cite journal}}: Cite journal requires |journal= (help)
Wittke, F.; Vincent, C.; Chen, J.; Heller, B.; Kabler, H.; Overcash, J. S.; Leylavergne, F.; Dieppois, G. (2020-09-21). "Afabicin, a First-in-Class Antistaphylococcal Antibiotic, in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Clinical Noninferiority to Vancomycin/Linezolid". Antimicrobial Agents and Chemotherapy. 64 (10): e00250-20. doi:10.1128/AAC.00250-20. PMC 7508579. PMID 32747361.

endpts.com (Global: low place; English: low place)

"Debiopharm, ITM ink up to €300M licensing deal for cancer treatment". Endpoints News. Retrieved 2025-02-20.

fiercebiotech.com (Global: low place; English: 8,828^th place)

"Merck KGaA drops xevinapant with ph. 3 trial headed for failure". www.fiercebiotech.com. 2024-06-25. Retrieved 2025-02-20.

finsmes.com (Global: low place; English: low place)

"Carevive Systems Raises Series C Financing". Finsmes. 2020-02-14.

fuw.ch (Global: low place; English: low place)

"Spezialist für Entwicklung von Krebsmedikamenten – Klein und unbekannt, aber hochprofitabel Ein Generalunternehmer für die Pharmaindustrie". Finanz und Wirtschaft (in German). 2002-04-03.

ggba.swiss (Global: low place; English: low place)

"Debiopharm invests CHF 30M in Valais amidst workforce surge". Greater Geneva Bern area. 2023-10-26. Retrieved 2025-02-20.

handle.net (Global: 102^nd place; English: 76^th place)

hdl.handle.net

World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. 2021. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. 2021. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
"Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck". 2022-02-17. doi:10.2217/fon-2021-1634. hdl:2434/1198462. PMID 35172587. {{cite journal}}: Cite journal requires |journal= (help)

informa.com (Global: low place; English: low place)

pink.pharmaintelligence.informa.com

Katie McQue (2009-06-26). "DebioPharm's Salvacyl launched in EU for sexual deviancy". Pharma Intelligence.

invivomagazine.com (Global: low place; English: low place)

Bernard Tappy (2013). "Debiopharm Research and Manufacturing SA". In Vivo Magazine.

lenouvelliste.ch (Global: low place; English: low place)

"Modernisé, Debiopharm va prendre de l'ampleur". Le Nouvelliste (in French). 2015-09-22.

letemps.ch (Global: 1,980^th place; English: 6,626^th place)

"Nous voulons acquérir une nouvelle société". Le Temps (in French). 2014-01-20.
Jean-Claude Péclet (2004-10-20). "L'ancien siège d'André à Lausanne reprend vie grâce au succès de Debiopharm". Le Temps.

manufacturingchemist.com (Global: low place; English: low place)

"Debiovision integrates into the Debio Group". Manufactiring Chemist. 2005-09-16.
"Debiopharm and MSM Protein Technologies sign oncology research agreement". Manufacturing Chemist. 2009-07-30.
"Debiopharm and Yale University sign worldwide agreement". Manufacturing Chemist. 2011-05-04.
"Evotec and Debiopharm to collaborate on development of new cancer treatment". Manufacturing Chemist. 2014-04-02.
"Debiopharm and Nobelex Biotech to develop antibiotics against N. Gonorrhoeae and enteric species". Manufacturing Chemist. 2014-07-01.
"Debiopharm continues fight against antibiotic resistance". Manufacturing Chemist. 2018-02-15.
"Debiopharm and Nobelex Biotech to develop antibiotics against N. Gonorrhoeae and enteric species". Manufactiring Chemist. 2014-07-01.

mddionline.com (Global: low place; English: low place)

"VivoSense Exits Stealth Mode with a Big Series A Round". MDDI Online. 2022-03-30.

mobihealthnews.com (Global: low place; English: low place)

"Cancer-focused Elekta snaps up digital oncology startup Kaiku Health". MobiHealthNews. 2020-05-20. Retrieved 2023-05-24.

moneyhouse.ch (Global: low place; English: low place)

"Debiopharm Investment SA". Money House.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Guillaume Ploussard; Pierre Mongiat-Artus (2013). "Triptorelin in the management of prostate cancer". Future Oncology (London, England). 9 (1): 93–102. doi:10.2217/fon.12.158. PMID 23252566.
Zhu, L.; Guan, Z.; Huang, Y.; Hua, K.; Ma, L.; Zhang, J.; Yang, D.; Perrot, V.; Li, H.; Zhang, X. (2022-02-04). "The efficacy and safety of triptorelin-therapy following conservative surgery for deep infiltrating endometriosis". Medicine. 101 (5) e28766. doi:10.1097/MD.0000000000028766. PMC 8812645. PMID 35119037.
"Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck". 2022-02-17. doi:10.2217/fon-2021-1634. hdl:2434/1198462. PMID 35172587. {{cite journal}}: Cite journal requires |journal= (help)
Wittke, F.; Vincent, C.; Chen, J.; Heller, B.; Kabler, H.; Overcash, J. S.; Leylavergne, F.; Dieppois, G. (2020-09-21). "Afabicin, a First-in-Class Antistaphylococcal Antibiotic, in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Clinical Noninferiority to Vancomycin/Linezolid". Antimicrobial Agents and Chemotherapy. 64 (10): e00250-20. doi:10.1128/AAC.00250-20. PMC 7508579. PMID 32747361.

ncbi.nlm.nih.gov

Zhu, L.; Guan, Z.; Huang, Y.; Hua, K.; Ma, L.; Zhang, J.; Yang, D.; Perrot, V.; Li, H.; Zhang, X. (2022-02-04). "The efficacy and safety of triptorelin-therapy following conservative surgery for deep infiltrating endometriosis". Medicine. 101 (5) e28766. doi:10.1097/MD.0000000000028766. PMC 8812645. PMID 35119037.
Wittke, F.; Vincent, C.; Chen, J.; Heller, B.; Kabler, H.; Overcash, J. S.; Leylavergne, F.; Dieppois, G. (2020-09-21). "Afabicin, a First-in-Class Antistaphylococcal Antibiotic, in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Clinical Noninferiority to Vancomycin/Linezolid". Antimicrobial Agents and Chemotherapy. 64 (10): e00250-20. doi:10.1128/AAC.00250-20. PMC 7508579. PMID 32747361.

oncozine.com (Global: low place; English: low place)

Hofland, Peter (2020-03-06). "Debio 0123, a Potent WEE1 Inhibitor, to be Assessed in First-in-human, Dose-escalation Study". Onco'Zine. Retrieved 2023-08-29.

pharmabiz.com (Global: low place; English: low place)

test.pharmabiz.com

"Debiopharm extends its Eloxatin collaboration with Sanofi-Synthelabo". Pharma Biz. 2002-08-28.

pharmaceutical-technology.com (Global: low place; English: low place)

"Debio-4326 by Debiopharm International for Central Precocious Puberty: Likelihood of Approval". Pharmaceutical Technology. 2023-12-21. Retrieved 2025-02-20.

pharmaphorum.com (Global: low place; English: low place)

deep-dive.pharmaphorum.com

"Enabling healthcare's digital future". Pharmaphorum Magazine. 2021.

pme.ch (Global: low place; English: low place)

"Thierry Mauvernay, le bien du patient comme boussole". pme (in Swiss French). Retrieved 2025-02-20.

reuters.com (Global: 49^th place; English: 47^th place)

"Merck agrees $1 billion deal with Debiopharm for head and neck cancer drug". Reuters. 2021-03-01. Retrieved 2023-02-13.
"Merck agrees $1 billion deal with Debiopharm for head and neck cancer drug". Reuters. 2021-03-01. Retrieved 2023-02-13.

theark.ch (Global: low place; English: low place)

"Debiopharm Research & Manufacturing". The Ark. 2016-05-15.

thepharmaletter.com (Global: low place; English: low place)

"Debiopharm and 3BP enter into global R&D deal for radioligand tech". The Pharma Letter. 2020-03-25.

yahoo.com (Global: 38^th place; English: 40^th place)

finance.yahoo.com

"Iktos raises € 15.5m Series A round to expand its artificial intelligence-based drug discovery technologies and solutions". Yahoo Finance. 2023-03-09.

Debiopharm (English Wikipedia)

24heures.ch (Global: 5,984th place; English: low place)

arznei-news.de (Global: low place; English: low place)

bioalps.org (Global: low place; English: low place)

bioprocessonline.com (Global: low place; English: low place)

bloomberg.com (Global: 99th place; English: 77th place)

business-monitor.ch (Global: low place; English: low place)

canal9.ch (Global: low place; English: low place)

cancer.gov (Global: 1,684th place; English: 1,350th place)

clinicaltrials.gov (Global: 5,225th place; English: 4,062nd place)

doi.org (Global: 2nd place; English: 2nd place)

endpts.com (Global: low place; English: low place)

fiercebiotech.com (Global: low place; English: 8,828th place)

finsmes.com (Global: low place; English: low place)

fuw.ch (Global: low place; English: low place)

ggba.swiss (Global: low place; English: low place)

handle.net (Global: 102nd place; English: 76th place)

hdl.handle.net

informa.com (Global: low place; English: low place)

pink.pharmaintelligence.informa.com

invivomagazine.com (Global: low place; English: low place)

lenouvelliste.ch (Global: low place; English: low place)

letemps.ch (Global: 1,980th place; English: 6,626th place)

manufacturingchemist.com (Global: low place; English: low place)

mddionline.com (Global: low place; English: low place)

mobihealthnews.com (Global: low place; English: low place)

moneyhouse.ch (Global: low place; English: low place)

nih.gov (Global: 4th place; English: 4th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

oncozine.com (Global: low place; English: low place)

pharmabiz.com (Global: low place; English: low place)

test.pharmabiz.com

pharmaceutical-technology.com (Global: low place; English: low place)

pharmaphorum.com (Global: low place; English: low place)

deep-dive.pharmaphorum.com

pme.ch (Global: low place; English: low place)

reuters.com (Global: 49th place; English: 47th place)

theark.ch (Global: low place; English: low place)

thepharmaletter.com (Global: low place; English: low place)

yahoo.com (Global: 38th place; English: 40th place)

finance.yahoo.com

24heures.ch (Global: 5,984^th place; English: low place)

bloomberg.com (Global: 99^th place; English: 77^th place)

cancer.gov (Global: 1,684^th place; English: 1,350^th place)

clinicaltrials.gov (Global: 5,225^th place; English: 4,062^nd place)

doi.org (Global: 2^nd place; English: 2^nd place)

fiercebiotech.com (Global: low place; English: 8,828^th place)

handle.net (Global: 102^nd place; English: 76^th place)

letemps.ch (Global: 1,980^th place; English: 6,626^th place)

nih.gov (Global: 4^th place; English: 4^th place)

reuters.com (Global: 49^th place; English: 47^th place)

yahoo.com (Global: 38^th place; English: 40^th place)